Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cerevance, Inc.
Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer
October 5, 2026
Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027
May 12, 2026
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
April 9, 2026
Cerevance to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026